BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3328519)

  • 21. Very long chain fatty acids in genetic peroxisomal disease fibroblasts: differences between the cerebro-hepato-renal (Zellweger) syndrome and adrenoleukodystrophy variants.
    Molzer B; Korschinsky M; Bernheimer H; Schmid R; Wolf C; Roscher A
    Clin Chim Acta; 1986 Nov; 161(1):81-90. PubMed ID: 3815856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients.
    Roscher AA; Hoefler S; Hoefler G; Paschke E; Paltauf F; Moser A; Moser H
    Pediatr Res; 1989 Jul; 26(1):67-72. PubMed ID: 2475849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very long-chain fatty acids in peroxisomal disease.
    Poulos A; Beckman K; Johnson DW; Paton BC; Robinson BS; Sharp P; Usher S; Singh H
    Adv Exp Med Biol; 1992; 318():331-40. PubMed ID: 1378993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency.
    Lazo O; Contreras M; Bhushan A; Stanley W; Singh I
    Arch Biochem Biophys; 1989 May; 270(2):722-8. PubMed ID: 2705786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peroxisomes and neurologic diseases].
    Sereni C; Paturneau-Jouas M
    Rev Neurol (Paris); 1989; 145(5):341-9. PubMed ID: 2472665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.
    Brown FR; McAdams AJ; Cummins JW; Konkol R; Singh I; Moser AB; Moser HW
    Johns Hopkins Med J; 1982 Dec; 151(6):344-51. PubMed ID: 7176294
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peroxisomes--in search of their function in man].
    Monnens L; Trijbels F; Govaerts L
    Tijdschr Kindergeneeskd; 1985 Aug; 53(4):129-36. PubMed ID: 3909510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
    Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
    J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperpipecolic acidemia in neonatal adrenoleukodystrophy.
    Kelley RI; Moser HW
    Am J Med Genet; 1984 Dec; 19(4):791-5. PubMed ID: 6517102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of branched chain fatty acids in peroxisomal disorders.
    Singh H; Usher S; Johnson D; Poulos A
    J Inherit Metab Dis; 1990; 13(3):387-9. PubMed ID: 1700192
    [No Abstract]   [Full Text] [Related]  

  • 31. Bile acids in peroxisomal disorders.
    Van Eldere JR; Parmentier GG; Eyssen HJ; Wanders RJ; Schutgens RB; Vamecq J; Van Hoof F; Poll-The BT; Saudubray JM
    Eur J Clin Invest; 1987 Oct; 17(5):386-90. PubMed ID: 2446876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
    Moser HW; Moser AE; Singh I; O'Neill BP
    Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infantile Refsum disease: an inherited peroxisomal disorder. Comparison with Zellweger syndrome and neonatal adrenoleukodystrophy.
    Poll-The BT; Saudubray JM; Ogier HA; Odièvre M; Scotto JM; Monnens L; Govaerts LC; Roels F; Cornelis A; Schutgens RB
    Eur J Pediatr; 1987 Sep; 146(5):477-83. PubMed ID: 2445576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Function and diseases of peroxisomes].
    Wehr H; Zaremba J
    Neurol Neurochir Pol; 1991; 25(6):769-74. PubMed ID: 1725818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adrenoleukodystrophy].
    Miyatake T
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):821-3. PubMed ID: 3270899
    [No Abstract]   [Full Text] [Related]  

  • 36. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
    J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complementation analysis of peroxisomal disorders and classical Refsum.
    Poll-The BT; Skjeldal OH; Stokke O; Demaugre F; Saudubray JM
    Prog Clin Biol Res; 1990; 321():537-43. PubMed ID: 1691507
    [No Abstract]   [Full Text] [Related]  

  • 38. History of the cerebrohepatorenal syndrome of Zellweger and other peroxisomal disorders.
    Zellweger H; Maertens P; Superneau D; Wertelecki W
    South Med J; 1988 Mar; 81(3):357-64. PubMed ID: 2450404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The peroxisomal disorders.
    Moser HW; Goldfischer SL
    Hosp Pract (Off Ed); 1985 Sep; 20(9):61-70. PubMed ID: 3928646
    [No Abstract]   [Full Text] [Related]  

  • 40. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
    Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO
    Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.